AstraZeneca-Fusion deal will need regulatory approvals in at least US, Canada
MLex Summary: AstraZeneca and Fusion Pharmaceuticals will seek to make US antitrust notification filings within five business days of their March 18 agreement and filings to Canada's Competition Bureau within 10...To view the full article, register now.
Already a subscriber? Click here to view full article